LAUNCH & PATIENT ACCESS CONCURRENT Required infrastructure for manufacturing advanced therapy products at mass scale
Friday, June 2, 2023 03:45 PM - 04:45 PM
Amphitheatre Bleu
LAUNCH & PATIENT ACCESS
Concurrent
Chair
Jon Rowley, PhD, Founder & Chief Product Officer, RoosterBio Inc., USA
Speakers
Geoff Mackay, President & CEO, AVROBIO Inc., USA
Antonio Lee, PhD, Global President, MEDIPOST, South Korea
Katy Spink, PhD, COO & Managing Partner, Dark Horse Consulting, USA
The goal of this session is to glean lessons from today’s commercial cell-based therapies and to use these lessons to lay the foundation for a future where Advanced Therapies are manufactured at scale and delivered to patients globally. What can product and process developers, and manufacturing and commercialization specialists do today to prepare for this future?
Jon Rowley, PhD, Founder & Chief Product Officer, RoosterBio Inc., USA
Speakers
Geoff Mackay, President & CEO, AVROBIO Inc., USA
Antonio Lee, PhD, Global President, MEDIPOST, South Korea
Katy Spink, PhD, COO & Managing Partner, Dark Horse Consulting, USA
The goal of this session is to glean lessons from today’s commercial cell-based therapies and to use these lessons to lay the foundation for a future where Advanced Therapies are manufactured at scale and delivered to patients globally. What can product and process developers, and manufacturing and commercialization specialists do today to prepare for this future?
